Latest Breaking News On - Andrzej chruscinski - Page 1 : comparemela.com

FSD Pharma Submits a Clinical Trial Protocol to Study the Safety and Efficacy of Unbuzzd(TM) in Acute Alcohol Intoxication

FSD Pharma Submits a Clinical Trial Protocol to Study the Safety and Efficacy of Unbuzzd(TM) in Acute Alcohol Intoxication
bignewsnetwork.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bignewsnetwork.com Daily Mail and Mail on Sunday newspapers.

United statesAndrzej chruscinskiZeeshan saeedLucid psycheceuticals incStrategic investments incScientific affairsPharma incCompany annual report on formHealth canadaCelly nutrition corpDrug administrationLucid psycheceuticalsCelly nutritionCelly nuInvestments incCanadian securities administrators

FSD Pharma Inc : FSD Pharma Submits a Clinical Trial Protocol to Study the Safety and Efficacy of Unbuzzd in Acute Alcohol Intoxication

TORONTO, ON / ACCESSWIRE / May 28, 2024 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech

United statesZeeshan saeedAndrzej chruscinskiScientific affairsPharma incStrategic investments incLucid psycheceuticals incDrug administrationCelly nutrition corpCompany annual report on formHealth canadaLucid psycheceuticalsCelly nutritionInvestments incCanadian securities administratorsAnnual report

FSD Pharma : Submits a Phase-1 Multiple Ascending Doses Clinical Trial Application for Lucid-21-302 (Lucid-MS) for Ethics Committee Review in Australia - Form 6-K

FSD Pharma : Submits a Phase-1 Multiple Ascending Doses Clinical Trial Application for Lucid-21-302 (Lucid-MS) for Ethics Committee Review in Australia - Form 6-K
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Andrzej chruscinskiZeeshan saeedEthics committeeClinical affairsPharma incCelly nutrition corpLucid psycheceuticals incStrategic investments incCompany annual report on formAscending doses clinicalEthics committee reviewMultiple ascending dose studyHealthy adult participantsNew chemical entityLucid psycheceuticalsCelly nutrition

FSD Pharma Submits a Phase-1 Multiple Ascending Doses Clinical Trial

FSD Pharma Submits a Phase-1 Multiple Ascending Doses Clinical Trial
pr-inside.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pr-inside.com Daily Mail and Mail on Sunday newspapers.

Andrzej chruscinskiLucid psycheceuticals incNews networkStrategic investments incCelly nutrition corpPharma incClinical affairsMultiple ascending dose studyHealthy adult participantsNew chemical entityLucid psycheceuticalsCelly nutritionInvestments incNote regarding forward looking informationClassb shares

FSD Pharma Inc : FSD Pharma Submits a Phase-1 Multiple Ascending Doses Clinical Trial Application for Lucid-21-302 for Ethics Committee Review in Australia

FSD Pharma Inc : FSD Pharma Submits a Phase-1 Multiple Ascending Doses Clinical Trial Application for Lucid-21-302 for Ethics Committee Review in Australia
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Zwei rohstoff chancenZeeshan saeedExperte carsten storkAndrzej chruscinskiPharma incCelly nutrition corpClinical affairsLucid psycheceuticals incStrategic investments incCompany annual report on formMultiple ascending dose studyHealthy adult participantsNew chemical entityLucid psycheceuticalsCelly nutritionInvestments inc